POM-V Prescription Required

Zulvac SBV Suspension for Injection for Cattle and Sheep

Active ingredient: Schmallenberg virus

Form

Injection

Species

Cattle Sheep

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5092

What it's used for

associated with infection by Schmallenberg virus. Onset of immunity: 2 weeks. Duration of immunity: 1 year. Sheep: For active immunisation of sheep from 3....

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Schmallenberg virus

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Zulvac SBV Suspension for Injection for Cattle and Sheep — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

associated with infection by Schmallenberg virus.
Onset of immunity: 2 weeks.
Duration of immunity: 1 year.
Sheep:
For active immunisation of sheep from 3.5 months of age to reduce viraemia*
associated with infection by Schmallenberg virus.
Onset of immunity: 3 weeks.
Duration of immunity: 6 months.
Vaccination of breeding sheep before pregnancy according to the recommended
schedule described in section 3.9 results in reduction of viraemia* and transplacental
infection associated with infection by Schmallenberg virus during the first trimester of
pregnancy.
*Below the level of detection by the validated RT-PCR method at 3.6 log10 RNA
copies/ml of plasma for cattle and at 3.4 log10 RNA copies/ml of plasma for sheep.

Cattle:
Intramuscular use (in the neck).
Primary vaccination:
- For cattle from 3.5 months of age: administer two doses of 2 ml three weeks apart.
Booster vaccination:
- Administer two doses of 2 ml three weeks apart, every year.
Sheep:
Subcutaneous use (in the axillar region behind the elbow).
Primary vaccination:
- For sheep from 3.5 months of age: administer one dose of 1 ml.
- For female sheep at breeding age: administer one dose of 1 ml at least 14 days
prior to breeding.
Booster vaccination:
- For non-breeding sheep: administer one dose of 1 ml, every 6 months.
- For female breeding sheep: administer one dose of 1 ml at least 14 days prior to
every breeding.

None.

Cattle:
Very common
(>1 animal / 10 animals treated):
Elevated temperature
Injection site granuloma
1
Transient, not exceeding 1.5 °C, during the first 48 hours after vaccination.
Intramuscular granulomas up to 0.7 cm in diameter which resolve in a maximum of
10 days.
Sheep:
Very common
(>1 animal / 10 animals treated):
Elevated temperature
Injection site swelling
1
Transient, not exceeding 1.5 °C, during the first 24 hours after vaccination.
Diffuse swelling or subcutaneous granulomas up to 8 cm in diameter. The reactions
were observed for at least 47 days in the form of diffuse swelling of less than 2 cm
diameter.
Pregnant ewe:
Very common
(>1 animal / 10 animals treated):
Elevated temperature
Injection site swelling
1
Transient, not exceeding 0.8 °C, during the first 4 hours after vaccination.
Diffuse swelling or subcutaneous granulomas up to 8 cm in diameter. The reactions
were observed for at least 97 days in the form of small granulomas of less than 0.5
cm in diameter.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.
No information is available on the use of the vaccine in seropositive animals
including those with maternally derived antibodies.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case-by-
case basis.

Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Protect from light.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.